About the Authors
- Shingai Machingaidze
-
* E-mail: missmachi@gmail.com (SM); charles.wiysonge@uct.ac.za (CSW)
¶SM and CSW contributed equally to this paper and share first authorship.
Affiliations Vaccines for Africa Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Division of Medical Microbiology, Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa
- Charles S. Wiysonge
-
* E-mail: missmachi@gmail.com (SM); charles.wiysonge@uct.ac.za (CSW)
¶SM and CSW contributed equally to this paper and share first authorship.
Affiliations Vaccines for Africa Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Division of Medical Microbiology, Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa
- Gregory D. Hussey
-
Affiliations Vaccines for Africa Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Division of Medical Microbiology, Department of Clinical Laboratory Sciences, University of Cape Town, Cape Town, South Africa
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Analyzed the data: SM CSW. Wrote the first draft of the manuscript: SM. Contributed to the writing of the manuscript: SM CSW. ICMJE criteria for authorship read and met: SM CSW GH. Agree with manuscript results and conclusions: SM CSW GH.